VitalGo, Inc. v. Kreg Therapeutics, Inc.

CourtDistrict Court, N.D. Illinois
DecidedMarch 27, 2019
Docket1:16-cv-05577
StatusUnknown

This text of VitalGo, Inc. v. Kreg Therapeutics, Inc. (VitalGo, Inc. v. Kreg Therapeutics, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
VitalGo, Inc. v. Kreg Therapeutics, Inc., (N.D. Ill. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

VITALGO, INC. and VITALGO ) SYSTEMS LTD., ) ) Case No. 16-cv-5577 Plaintiff, ) ) Judge Robert M. Dow, Jr. v. ) ) ) KREG THERAPEUTICS, INC. and ) CRAIG POULOS, ) ) Defendants. )

MEMORANDUM OPINION AND ORDER Plaintiffs VitalGo, Inc. (“VitalGo”) and VitalGo Systems Ltd. (collectively, “Plaintiffs”) bring this action against Defendants Kreg Therapeutics, Inc. (“Kreg”) and Craig Poulos (collectively, “Defendants”) alleging copyright and trademark infringement and unfair competition under federal and state law. Currently before the Court is Defendants’ combined motion [77] to strike portions of Plaintiffs’ Second Amended Complaint and to dismiss all claims in the Second Amended Complaint with prejudice. For the reasons stated below, Defendants’ motion [77] is granted in part and denied in part. The Court grants Defendants’ motion to strike in part as follows: portions of paragraphs 29, 51, 60, 122, 131, 159, 167, and 180 (29(1), 51(i), 60 (last sentence), 122 (last clause), 131(i), 159(i), 167(i), 180(i)) are stricken from the Second Amended Complaint as they address claims that this Court has previously dismissed. Furthermore, the Court grants Defendants’ motion to dismiss Count III, and denies Defendants’ motion as to Count I, Count II, Count IV, Count V, Count VI, and Count VII. This case is set for further status hearing on April 10, 2019 at 9:30 a.m. I. Background1 The background of this case, and of the more extensive litigation in which VitalGo and Kreg have been engaged before this Court, is set forth in the Court’s previous opinions in this case, knowledge of which is assumed here. [See 41, at 1–7; 67, at 1–4.] Briefly summarized, the parties

entered into an agreement pursuant to which Kreg was granted the exclusive right to distribute Plaintiffs’ Total Lift Bed product in certain regions of the country. In 2011, VitalGo terminated the parties’ agreement, and Kreg thereafter filed suit (the “2011 Lawsuit”) against VitalGo for breach of that agreement. VitalGo counterclaimed that Kreg had violated the parties’ agreement by both making unauthorized alterations to the Total Lift Bed without VitalGo’s prior written approval and by failing to obtain VitalGo’s approval of all advertisements and promotional materials Kreg used to promote and sell Total Lift Beds. The 2011 Lawsuit ended after a bench trial in which the Court concluded that Kreg was entitled to $642,610 in damages plus $364,593 in prejudgment interest, for a total award of $1,007,203. See Kreg Therapeutics, Inc. v. Vitalgo, Inc., Dkt. Entry 250, No. 11-cv-6771 (N.D. Ill.). The Seventh Circuit recently affirmed that

judgment. See Kreg Therapeutics, Inc. v. VitalGo, Inc., --- F.3d ---, 2019 WL 1198376 (7th Cir. Mar. 14, 2019). In May 2016, Plaintiffs filed the instant lawsuit, bringing claims against Defendants for copyright infringement in violation of 17 U.S.C. § 501 (Count I); unfair competition and false designation of origin pursuant to Section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a)(1)(A) (Count II); unfair competition and false advertisement pursuant to Section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a)(1)(B) (Count III); common law trademark infringement (Count IV);

1 For purposes of the motion to dismiss, the Court accepts as true all of Plaintiff’s well-pleaded factual allegations and draws all reasonable inferences in Plaintiff’s favor. Killingsworth v. HSBC Bank Nev., N.A., 507 F.3d 614, 618 (7th Cir. 2007). common law unfair competition (Count V); violation of the Illinois Uniform Deceptive Trade Practices Act (IUDTPA), 815 Ill. Comp. Stat. 510/1 et seq. (Count VI); and violation of the Illinois Consumer Fraud and Deceptive Business Practices Act (ICFA), 815 Ill. Comp. Stat. 505/1 et seq. (Count VII). [1, ¶ 2.] According to the original complaint, Plaintiffs began using the VitalGo and

TOTAL LIFT BED marks in the United States in 2008; Plaintiffs began showing the Total Lift Bed in advertising and marketing materials in approximately 2008; and Plaintiffs have filed copyright applications for a brochure and for two digital renderings of the Total Lift Bed. [1, ¶¶ 14, 18.] Plaintiffs alleged that (1) Defendants marketed Plaintiffs’ Total Lift Bed as an “Exclusive Kreg Product” or as a “Kreg Bed” and used Plaintiffs’ Copyrighted Works in doing so since October 2011; (2) Defendants made modifications to Plaintiffs’ Total Lift Beds but continued to advertise them as Total Lift Beds in 2010 or 2011; and (3) Defendants developed the Kreg Catalyst Bed in 2014 to compete with the Total Lift Bed and, until March 2016, they promoted the Catalyst Bed using the Total Lift Bed mark and Plaintiffs’ Copyrighted Works. [41, at 7.] Defendants moved to dismiss [18] Plaintiffs’ complaint in July 2016. In support of their

motion, Defendants argued that (1) Plaintiffs were judicially estopped from asserting their claims; (2) Plaintiffs’ claims could not be alleged in an independent lawsuit because they constituted impermissible claim splitting; (3) no factual allegations demonstrated Defendant Poulos’s personal liability; (4) the doctrine of laches barred Plaintiffs’ Lanham Act claims; (5) Plaintiffs did not allege actual consumer reliance on Defendants’ alleged misleading advertisements as necessary to support its Lanham Act claims; and (6) Plaintiffs could not seek attorneys’ fees under the Copyright Act. On March 29, 2017, the Court granted in part and denied in part Defendants’ motion. [See 41.] The Court held that the doctrine of claim splitting precluded Plaintiffs from bringing claims against Defendants relating to Defendants’ modifications to the Total Lift Bed and to Defendants’ allegedly infringing marketing and promotional materials for the Total Lift Bed because those claims were based on the same set of operative facts underlying VitalGo’s counterclaim in the 2011 Lawsuit. [41, at 9–18.] However, the Court determined that Plaintiffs could proceed with their claims to the extent the claims were based on Defendants’ alleged

marketing of their Catalyst Bed using Plaintiffs’ intellectual property because the underlying facts on which the allegations were based were separate and distinct from those underlying Plaintiff VitalGo’s counterclaims in the 2011 Lawsuit. [41, at 18–19.] The Court also dismissed Plaintiffs’ claims for attorneys’ fees pursuant to § 505 of the Copyright Act. [41, at 27.] Plaintiffs then filed their First Amended Complaint on May 3, 2017. [See 43.] Defendants responded on May 31, 2017 by filing a motion [49] to strike various allegations from the First Amended Complaint concerning the Total Lift Bed pursuant to Federal Rule of Civil Procedure (“Rule”) 12(f) and to dismiss the remaining claims in the First Amended Complaint pursuant to Rule 12(b)(6). To support their motion, Defendants asserted (1) that the majority of the factual allegations contained in Plaintiffs’ First Amended Complaint had to be stricken because they only

related to the previously dismissed claims, and (2) that once the irrelevant allegations against them were removed pursuant to Rule 12(f), the First Amended Complaint would be insufficient to support the remaining claims under either the heightened pleading standard of Rule 9(b) (for Counts II–III and V–VII) or the regular pleading standard of Rule 8(a) (for Counts I and IV).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. MacK
295 U.S. 480 (Supreme Court, 1935)
Allen v. McCurry
449 U.S. 90 (Supreme Court, 1980)
Zedner v. United States
547 U.S. 489 (Supreme Court, 2006)
Atkins v. City of Chicago
631 F.3d 823 (Seventh Circuit, 2011)
Clovis Carl Green, Jr. v. Warden, U.S. Penitentiary
699 F.2d 364 (Seventh Circuit, 1983)
Web Printing Controls Co., Inc. v. Oxy-Dry Corporation
906 F.2d 1202 (Seventh Circuit, 1990)
Palka v. City of Chicago
662 F.3d 428 (Seventh Circuit, 2011)
Hot Wax, Inc. v. Turtle Wax, Inc.
191 F.3d 813 (Seventh Circuit, 1999)
Robert H. Tice v. American Airlines, Inc.
373 F.3d 851 (Seventh Circuit, 2004)
James A. Knight v. Bank of America
695 F.3d 714 (Seventh Circuit, 2012)
Tamayo v. Blagojevich
526 F.3d 1074 (Seventh Circuit, 2008)
Killingsworth v. HSBC Bank Nevada, N.A.
507 F.3d 614 (Seventh Circuit, 2007)
Cumis Insurance Society, Inc. v. Peters
983 F. Supp. 787 (N.D. Illinois, 1997)
Petrella v. Metro-Goldwyn-Mayer, Inc.
134 S. Ct. 1962 (Supreme Court, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
VitalGo, Inc. v. Kreg Therapeutics, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/vitalgo-inc-v-kreg-therapeutics-inc-ilnd-2019.